These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 15563562

  • 1. Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study.
    Winkelmayer WC, Kramar R, Curhan GC, Chandraker A, Endler G, Födinger M, Hörl WH, Sunder-Plassmann G.
    J Am Soc Nephrol; 2005 Jan; 16(1):255-60. PubMed ID: 15563562
    [Abstract] [Full Text] [Related]

  • 2. Prognostic associations between lipid markers and outcomes in kidney transplant recipients.
    Schaeffner ES, Födinger M, Kramar R, Frei U, Hörl WH, Sunder-Plassmann G, Winkelmayer WC.
    Am J Kidney Dis; 2006 Mar; 47(3):509-17. PubMed ID: 16490631
    [Abstract] [Full Text] [Related]

  • 3. Impact of homocysteinemia on long-term renal transplant survival.
    Fonseca I, Martins L, Queirós J, Mendonça D, Dias L, Sarmento AM, Henriques AC, Cabrita A.
    Transplant Proc; 2005 Mar; 37(6):2784-8. PubMed ID: 16182810
    [Abstract] [Full Text] [Related]

  • 4. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.
    Suliman M, Stenvinkel P, Qureshi AR, Kalantar-Zadeh K, Bárány P, Heimbürger O, Vonesh EF, Lindholm B.
    Nephrol Dial Transplant; 2007 Jan; 22(1):209-17. PubMed ID: 16982634
    [Abstract] [Full Text] [Related]

  • 5. Serum total homocysteine concentration does not predict outcome in renal transplant recipients.
    Dimény E, Hultberg B, Wahlberg J, Fellström B, Arnadottir M.
    Clin Transplant; 1998 Dec; 12(6):563-8. PubMed ID: 9850451
    [Abstract] [Full Text] [Related]

  • 6. Elevated homocysteine is a predictor of all-cause mortality in a prospective cohort of renal transplant recipients.
    Connolly GM, Cunningham R, McNamee PT, Young IS, Maxwell AP.
    Nephron Clin Pract; 2010 Dec; 114(1):c5-11. PubMed ID: 19797932
    [Abstract] [Full Text] [Related]

  • 7. Increasing plasma homocysteine during follow-up in heart transplant recipients: effects of folate and renal function.
    Potena L, Grigioni F, Magnani G, Sorbello S, Sassi S, Marinucci L, Conti R, Carinci V, Leone O, Arpesella G, Coccheri S, Magelli C, Branzi A.
    Ital Heart J; 2000 May; 1(5):344-8. PubMed ID: 10832810
    [Abstract] [Full Text] [Related]

  • 8. Restless legs syndrome and mortality in kidney transplant recipients.
    Molnar MZ, Szentkiralyi A, Lindner A, Czira ME, Szeifert L, Kovacs AZ, Fornadi K, Szabo A, Rosivall L, Mucsi I, Novak M.
    Am J Kidney Dis; 2007 Nov; 50(5):813-20. PubMed ID: 17954294
    [Abstract] [Full Text] [Related]

  • 9. Omega-3 fatty acid supplementation and total homocysteine levels in end-stage renal disease patients.
    Beavers KM, Beavers DP, Bowden RG, Wilson RL, Gentile M.
    Nephrology (Carlton); 2008 Jun; 13(4):284-8. PubMed ID: 18331436
    [Abstract] [Full Text] [Related]

  • 10. Patient and graft outcomes from deceased kidney donors age 70 years and older: an analysis of the Organ Procurement Transplant Network/United Network of Organ Sharing database.
    Chavalitdhamrong D, Gill J, Takemoto S, Madhira BR, Cho YW, Shah T, Bunnapradist S.
    Transplantation; 2008 Jun 15; 85(11):1573-9. PubMed ID: 18551062
    [Abstract] [Full Text] [Related]

  • 11. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.
    Vianna AC, Mocelin AJ, Matsuo T, Morais-Filho D, Largura A, Delfino VA, Soares AE, Matni AM.
    Hemodial Int; 2007 Apr 15; 11(2):210-6. PubMed ID: 17403173
    [Abstract] [Full Text] [Related]

  • 12. Determinants of fasting total serum homocysteine levels in liver transplant recipients.
    Akoglu B, Wondra K, Caspary WF, Faust D.
    Exp Clin Transplant; 2006 Jun 15; 4(1):462-6. PubMed ID: 16827644
    [Abstract] [Full Text] [Related]

  • 13. Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy.
    Suliman ME, Stenvinkel P, Qureshi AR, Bárány P, Heimburger O, Anderstam B, Alvestrand A, Lindholm B.
    Am J Kidney Dis; 2004 Sep 15; 44(3):455-65. PubMed ID: 15332218
    [Abstract] [Full Text] [Related]

  • 14. Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality.
    Bunnapradist S, Neri L, Wong W, Lentine KL, Burroughs TE, Pinsky BW, Takemoto SK, Schnitzler MA.
    Am J Kidney Dis; 2008 Mar 15; 51(3):478-86. PubMed ID: 18295064
    [Abstract] [Full Text] [Related]

  • 15. Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial.
    Bostom AG, Carpenter MA, Kusek JW, Hunsicker LG, Pfeffer MA, Levey AS, Jacques PF, McKenney J, FAVORIT Investigators.
    Am Heart J; 2006 Sep 15; 152(3):448.e1-7. PubMed ID: 16923411
    [Abstract] [Full Text] [Related]

  • 16. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
    Sjöberg B, Anderstam B, Suliman M, Alvestrand A.
    Am J Kidney Dis; 2006 Jan 15; 47(1):60-71. PubMed ID: 16377386
    [Abstract] [Full Text] [Related]

  • 17. Effects of single-nucleotide polymorphisms in MTHFR and MTRR on mortality and allograft loss in kidney transplant recipients.
    Winkelmayer WC, Kramar R, Sunder-Plassmann G, Födinger M.
    Kidney Int; 2005 Dec 15; 68(6):2857-62. PubMed ID: 16316363
    [Abstract] [Full Text] [Related]

  • 18. Association between plasma homocysteine levels and coronary artery disease: a population-based study in northern Greece.
    Boufidou AI, Makedou AD, Adamidis DN, Karvounis HI, Gourassas JT, Kesidis HT, Makedou KG, Papadopoulos CE, Parharidis GE, Louridas GE.
    Curr Med Res Opin; 2004 Dec 15; 20(2):175-80. PubMed ID: 15006011
    [Abstract] [Full Text] [Related]

  • 19. Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients--Italian initiative on uremic hyperhomocysteinemia (IIUH).
    Perna AF, Ingrosso D, Molino D, Galletti P, Montini G, Zacchello G, Bellantuono R, Caringella A, Fede C, Chimenz R, De Santo NG.
    J Nephrol; 2003 Dec 15; 16(4):516-21. PubMed ID: 14696753
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.